Salary Range: 21.5 to 21.5 (Currency: USD) (Pay period: per-hour-wage)
TerrAscend Corp. is a leading TSX-listed company with operations across North America, including Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp., as well as retail operations in Canada.
TerrAscend operates The Apothecarium and other dispensary retail locations, along with scaled cultivation, processing, and manufacturing facilities across its core markets. Our portfolio includes well-known brands such as The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One, and Valhalla.
*Benefits and eligibility may vary based on employment status, location, and other applicable factors.*
Background Check Requirement
As a condition of employment, a complete background investigation will be conducted based on the rules of the specific State in which the employee is hired. Typically, the state investigative process includes a state and federal background check.
Working Conditions
This position may require the ability to perform essential functions that include, but are not limited to, standing, walking, bending, reaching, and lifting. Team members may need to lift and move items, e.g., product packages, display cases, cash registers, or inventory boxes, weighing up to 50 pounds, with or without reasonable accommodation.
The role may also require visual abilities to accurately handle transactions, verify product information, and maintain inventory, as well as manual dexterity for handling cash, operating point-of-sale systems, and organizing products. Employees may be required to remain on their feet for extended periods and perform repetitive hand or arm movements with or without reasonable accommodation.
EEO Statement
TerrAscend is an equal opportunity employer. At TerrAscend, employees and applicants are evaluated based on their qualifications, skills, and ability to perform the duties and responsibilities of the position. In accordance with applicable law, we prohibit discrimination based on sex, race, color, religion, gender, pregnancy or related medical conditions, age, national origin or ancestry, physical or mental disability, genetic information, sexual orientation, veteran status, or any other consideration protected by federal, state or local laws.
Disclaimer
This job description is not an employment agreement or contract. The Company has the exclusive right to alter this job description at any time without notice. The list of job responsibilities, skills, duties, requirements, and the like is not exhaustive, rather it is illustrative of the current essential functions required for the position.
TerrAscend Participates in E-Verify
Please review the E-Verify Participation Notice and Right to Work Notice, available in English and Spanish.
E-Verify Participation Notice:
https://www.e-verify.gov/sites/default/files/everify/posters/EVerifyParticipationPoster.pdf
Right to Work Notice:
https://www.e-verify.gov/sites/default/files/everify/posters/IER_RighttoWorkPoster.pdf
Statement on External Recruiting Agencies
TerrAscend and all affiliates do not accept blind resume submissions from external recruiting agencies. No fee will be paid to agencies who submit candidates without being under contract for an active search with TerrAscend.
TerrAscend operates globally in the cannabis sector, covering cultivation, processing, manufacturing, and retail. It grows cannabis plants, turns them into products such as dried flowers, oils, edibles, and other infused goods, and sells these through its own retail brands and distribution channels. The company also provides ancillary services to support the cannabis industry. What makes TerrAscend different is its integrated, multi-country footprint and strategy of strategic acquisitions (including Arise Bioscience, The Apothecarium, State Flower, and Ilera Healthcare) to expand its brands and market presence, while maintaining strong standards for quality and regulatory compliance grounded in scientific research. Its goal is to continue growing its market position by expanding its product range, geographic reach, and capabilities through innovation, rigorous quality control, and acquisitions, serving medical patients, recreational users, and other cannabis industry businesses.
Company Size
201-500
Company Stage
IPO
Headquarters
Mississauga, Canada
Founded
2017
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
TerrAscend closes Aunt Mary's deal while TerrAscend stock trades at EUR 0.44. Published on 10/15/2026 at 12:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS Aunt Mary's gives TerrAscend a fifth New Jersey store. TerrAscend stock trades at EUR 0.44 on October 15, 2026 with a CAD 207.1 million TSX market cap. Retail expansion and quarterly figures. * On September 16, 2026, TerrAscend closed a USD 9 million Aunt Mary's transaction. * Second-quarter 2026 revenue reached USD 67.1 million, with a 54.0 percent gross margin. * TerrAscend stock was trading at EUR 0.44 at 12:41 p.m. CEST at Lang & Schwarz on October 15, 2026. TerrAscend (ISIN CA88105E1088) trades at EUR 0.44 at Lang & Schwarz on October 15, 2026 at 12:41 p.m. CEST, while its latest expansion adds a fifth New Jersey dispensary. The company closed the Aunt Mary's transaction on September 16, 2026, according to TerrAscend. Discover more Read Company News Read Economics Trade Forex Three expansion milestones. In June 2026, TerrAscend agreed to total consideration of USD 9 million for the Aunt Mary's transaction, including a USD 3 million five-year convertible debenture carrying 6.0 percent interest and USD 6 million payable in cash upon exercise of an option. The September 16, 2026 closing gave the company its fifth New Jersey retail location and a path to a consolidated footprint of 21 dispensaries across five U.S. states and Canada, the company release said. On August 6, 2026, TerrAscend reported second-quarter 2026 revenue of USD 67.1 million, up 3.3 percent year over year, while gross margin reached 54.0 percent. Zacks reported that adjusted EBITDA margin was 26.3 percent and free cash flow was USD 5.7 million in the quarter. What does the deal add? Aunt Mary's generates more than USD 10 million in annualized revenue, giving the acquisition a measurable operating footprint beyond its store count. The company said the location should be immediately accretive to EBITDA and free cash flow, although full consolidation depends on exercising the option and satisfying additional conditions. Next reporting date. ToAlpha lists November 12, 2026 as TerrAscend's next reporting date. That date would put third-quarter 2026 results next in the company calendar after the second-quarter figures reported on August 6, 2026. Stock price and company scale. Discover more Invest in Stocks TerrAscend's market value was CAD 207.1 million on October 14, 2026, with a TSX 52-week range of CAD 0.53 to CAD 2.00. The current euro quotation is therefore best read alongside the company's operating progress and its still developing New Jersey retail base. TerrAscend was trading at EUR 0.44 at Lang & Schwarz on October 15, 2026 at 12:41 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of TerrAscend stock. TerrAscend stock at a glance. * Company: TerrAscend Corp. * ISIN: CA88105E1088 * Ticker: TSND * Primary exchange: TSX * Price Lang & Schwarz (as of October 15, 2026, 12:41 p.m. CEST): EUR 0.44 * Market capitalization: CAD 207.1 million (as of October 14, 2026) * 52-week range: CAD 0.53-2.00 (as of October 14, 2026) * Sector / Industry: Healthcare / Drug Manufacturers - Specialty and Generic Sponsored Ad Discover more Find Stress Relief Find Support Track Biotech Terrascend stock: New analysis - 22 October. Fresh Terrascend information released. What's the impact for investors? Our latest independent report examines recent figures and market trends. Disclaimer regarding our articles: This is not investment advice, nor is it a recommendation to buy or sell. Information regarding prices, companies, and markets is provided without guarantee; changes may occur at any time. Stock market transactions can result in significant losses. Our articles are created and reviewed, in whole or in part, automatically with the assistance of AI. en | CA88105E1088 | TSND | boerse | 70329101 | bgmi
TerrAscend closes $9M deal for NJ cannabis dispensary. Multistate operator TerrAscend has snagged another dispensary in Hunterdon County. Under the terms of the transaction, TerrAscend will commit a total of $9 million. That figure includes $3 million in the form of a five-year unsecured convertible promissory note at 6% that provides the option to take a 35% stake in the company, as well as an additional $6 million in cash if TerrAscend exercises the option. TerrAscend has said Aunt Mary's will continue operating under the same name. Located at The Shoppes at Flemington, Aunt Mary's opened in February 2023. The 5,200-square-foot shop initially served medical patients only, but later expanded to welcome adult-use customers after securing New Jersey Cannabis Regulatory Commission approval. Joining the family. Commenting on the latest acquisition, TerrAscend Executive Chairman Jason Wild said, "Aunt Mary's generates more than $10 million in annualized revenue today, and we see meaningful opportunities to enhance sales and profitability through the integration of our premium brand portfolio. We are excited to welcome the Aunt Mary's team to the TerrAscend family." Based in Toronto, TerrAscend's retail footprint of roughly 20 dispensaries spans five U.S. states and Canada. It also has cultivation, processing and manufacturing facilities in core markets. Within New Jersey, TerrAscend also runs The Apothecarium dispensaries in Lodi, Maplewood and Phillipsburg. The buyout came less than two years after Union Chill opened as Hunterdon County's first recreational dispensary. That shop remains open under its original name.
TerrAscend now has until September 18 to respond to federal 280E lawsuit seeking return of $8.4 million marijuana tax refund. Marijuana company TerrAscend now has until September 18 to respond to a federal lawsuit seeking the return of more than $8.3 million in tax refunds tied to the company's challenge to Section 280E of the federal tax code. According to an updated federal court docket, TerrAscend USA Inc. and its subsidiaries were served with the lawsuit in late August, establishing a September 18 deadline to answer the complaint or otherwise respond. The case, United States v. TerrAscend USA, Inc. & Subsidiaries, is pending in the U.S. District Court for the District of New Jersey. The September deadline could produce TerrAscend's first substantive court filing explaining how it intends to defend its position. The company could file an answer responding to the government's allegations or seek dismissal of some or all of the case through a motion. The Department of Justice filed the lawsuit on May 18 on behalf of the federal government, alleging that TerrAscend received an erroneous refund after amending its federal income tax return for 2020. TerrAscend originally reported no business deductions on its 2020 return but later amended the filing to claim approximately $64.6 million in deductions. The Internal Revenue Service subsequently issued the company a refund of approximately $8.36 million. The federal government argues those deductions were prohibited by Section 280E, which generally prevents businesses trafficking in Schedule I or Schedule II controlled substances from deducting ordinary business expenses. TerrAscend has indicated that it intends to fight the government's effort. In its most recent quarterly filing, the company said the Justice Department initially contacted it on April 6 seeking repayment of approximately $9.53 million, including an estimated $1.17 million in interest. The company said it "believes it has substantive defenses to the assertions raised" and intends to "vigorously defend its position." TerrAscend also said that, based on information available to it and consultation with outside legal and tax advisers, it does not currently consider a loss in the case probable. The dispute could have implications beyond TerrAscend. Several large marijuana companies have challenged the application of 280E in recent years, including by filing amended tax returns seeking refunds for taxes previously paid. The IRS has maintained that marijuana businesses were not entitled to refunds based on such amended returns and said in 2024 that it was taking steps to address the claims. TerrAscend's case may provide one of the first significant tests of how federal courts will handle those refund strategies, particularly as federal marijuana scheduling and the future application of Section 280E continue to change.
TerrAscend to participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference. MWN-AI** Summary. TerrAscend Corp. ("TerrAscend"), a prominent player in the North American cannabis industry, has announced its participation in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference, scheduled for September 9, 2026, in New York City. The company's executive team, including Executive Chairman Jason Wild and Chief Executive Officer Ziad Ghanem, will conduct one-on-one meetings throughout the event, signaling their commitment to engaging with institutional investors. Founded as a TSX-listed cannabis company, TerrAscend operates extensively across key markets in North America, including Pennsylvania, New Jersey, Maryland, Ohio, and California. The firm is recognized for its expansive retail operations through dispensaries such as The Apothecarium, as well as its robust cultivation, processing, and manufacturing capabilities. With a focus on quality, TerrAscend employs advanced cultivation and manufacturing practices to deliver a diverse and high-quality product selection, catering effectively to both medical and adult-use cannabis markets. TerrAscend's business model includes ownership and licensing of various synergistic brands such as Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One, and Valhalla, further solidifying its position within the industry. By participating in the institutional investor conference, TerrAscend aims to enhance its visibility among potential investors and showcase its strategic growth initiatives and product offerings. As the cannabis sector continues to evolve, TerrAscend's proactive approach to investor engagement demonstrates its strength in navigating the complexities of the market while aiming to maximize shareholder value. For more information about TerrAscend Corp and its offerings, interested parties can visit the company's official website or reach out to its investor relations team. MWN-AI** Analysis. TerrAscend Corp. (TSX: TSND, OTCQX: TSNDF) is poised to capture market interest, particularly with its upcoming participation in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference. This event on September 9 presents a strategic opportunity for TerrAscend's executive management, including Executive Chairman Jason Wild and CEO Ziad Ghanem, to engage with investors and showcase the company's growth potential. TerrAscend has established itself as a key player in the North American cannabis sector, with a diversified operational footprint spanning multiple lucrative markets, including Pennsylvania, New Jersey, Maryland, Ohio, and California. Its robust business model encompasses cultivation, processing, and retail, underpinned by a commitment to high-quality cannabis production for both medical and adult-use segments. With established brands like The Apothecarium and partnerships with companies like Cookies and Wana, TerrAscend stands out for its diverse product offering and brand synergy. The current state of the cannabis market, characterized by evolving legislation and increasing public acceptance, bodes well for companies like TerrAscend. This strategic positioning, coupled with the company's operational efficiencies and market penetration, could lead to favorable revenue trajectory in the near term. Investors should view TerrAscend's engagement at the conference as a pivotal moment for potential insights into the company's growth strategies and financial outlook. Interest in the cannabis sector remains high, and with management actively communicating their vision, this could translate into increased investor confidence and share price appreciation. In summary, for investors considering exposure to the cannabis industry, TerrAscend represents a compelling proposition, especially in light of its strong market presence and proactive investor engagement. Keeping an eye on developments from the upcoming conference could provide valuable insights for making informed investment decisions. **MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release. September 04, 2026 12:30:00 pm TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) - TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference held in New York City, on September 9, 2026. Jason Wild, Executive Chairman and Ziad Ghanem, Chief Executive Officer, will host one-on-one meetings throughout the conference. About TerrAscend Corp. TerrAscend Corp. is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla. For more information visit www.terrascend.com. Investor Relations Contact: KCSA Strategic Communications Valter Pinto, Managing Director [email protected] 212-896-1254 FAQ**. How does TerrAscend Corp TSNDF plan to leverage its presence at the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference to enhance investor relations and stakeholder engagement? TerrAscend Corp TSNDF aims to leverage its presence at the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference by showcasing its strategic initiatives and innovations to enhance transparency and foster closer relationships with investors and stakeholders. What specific goals does TerrAscend Corp TSNDF aim to achieve during the one-on-one meetings hosted by Jason Wild and Ziad Ghanem at the upcoming investor conference? TerrAscend Corp aims to communicate its growth strategy, showcase recent operational developments, and discuss financial performance and future projections during the one-on-one meetings hosted by Jason Wild and Ziad Ghanem at the upcoming investor conference. Can you provide insight into how TerrAscend Corp TSNDF's recent operational developments in Pennsylvania, New Jersey, and California are expected to impact its growth strategy moving forward? TerrAscend Corp's recent operational developments in Pennsylvania, New Jersey, and California are anticipated to bolster its growth strategy by expanding market reach, enhancing product offerings, and increasing revenue streams in key cannabis markets, driving overall profitability. What strategies is TerrAscend Corp TSNDF implementing to maintain its competitive edge in the evolving North American cannabis market, particularly with its diverse portfolio of brands? TerrAscend Corp is focusing on innovation through product diversification, expanding its distribution channels, enhancing brand recognition, and investing in sustainability to maintain its competitive edge in the evolving North American cannabis market. **MWN-AI FAQ is based on asking OpenAI questions about TerrAscend Corp (OTC: TSNDF).
TerrAscend to participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference. September 04, 2026 12:30 ET | Source: TerrAscend TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) - TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced that its executive management team will participate in the ATB Cormark Capital Markets 2026 Life Sciences Fall Institutional Investor Conference held in New York City, on September 9, 2026. Jason Wild, Executive Chairman and Ziad Ghanem, Chief Executive Officer, will host one-on-one meetings throughout the conference. About TerrAscend Corp. TerrAscend Corp. is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including operations in Pennsylvania, New Jersey, Maryland, Ohio, and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla. For more information visit www.terrascend.com. Investor Relations Contact: KCSA Strategic Communications Valter Pinto, Managing Director [email protected] 212-896-1254